$10.15
-0.2-1.93%
At Close: -
$10.21
0.060.56%
After Hours: 7:57 PM EDT
15 minutes delayed
Comments
Loading...
Iovance Biotherapeutics (NASDAQ:IOVA) Stock, Earnings Estimates, EPS, And Revenue
Iovance Biotherapeutics reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Earnings Date
Nov 5
EPS Estimate
$-0.300
Quarterly Revenue Estimate
$53.8M
Annual Revenue
(as of Jun 30)
(as of Jun 30)
$32.8M
Analyze the earnings history of Iovance Biotherapeutics using advanced sorting and filters.
Data brought to you by Benzinga APIs
Iovance Biotherapeutics (IOVA) Earnings Per Share
Quarterly Earnings Surprise Amount
| Fiscal Quarter End | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Jun 2024 | 2024-08-08 | $-0.34 | $-0.35 | 2.86 % |
| Mar 2024 | 2024-05-09 | $-0.42 | $-0.42 | 0.00 % |
| Dec 2023 | 2024-02-28 | $-0.45 | $-0.43 | -4.65 % |
| Sep 2023 | 2023-11-07 | $-0.46 | $-0.45 | -2.22 % |
Iovance Biotherapeutics (IOVA) Revenue
Quarterly Revenue Surprise Amount
| Fiscal Quarter End | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
| Jun 2024 | 2024-08-08 | $31.11M | $27.07M | 14.9 % |
| Mar 2024 | 2024-05-09 | $715.00K | $2.07M | -65.5 % |
| Sep 2023 | 2023-11-07 | $469.00K | $4.19M | -88.8 % |
| Jun 2023 | 2023-08-08 | $238.00K | $3.58M | -93.3 % |
FAQ
When is Iovance Biotherapeutics (NASDAQ:IOVA) reporting earnings?
Iovance Biotherapeutics (IOVA) is scheduled to report earnings on November 5, 2024. The last reported earnings were for reported on August 8, 2024 for Q2.
What were the latest earnings per share (EPS) for Iovance Biotherapeutics (NASDAQ:IOVA)?
The Actual EPS was $-0.34, which beat the estimate of $-0.35.
What were Iovance Biotherapeutics’s (NASDAQ:IOVA) revenues?
The Actual Revenue was $31.1M, which beat the estimate of $27.1M.
Browse earnings estimates, EPS, and revenue on all stocks.